Literature DB >> 27796866

Percutaneous Mitral Valve Repair with MitraClip: Patient and Valve Selection for Optimal Outcome.

Devdas T Inderbitzin1, Maurizio Taramasso2, Fabian Nietlispach3, Francesco Maisano2.   

Abstract

In the real world of mitral regurgitation, the patient selection process for MitraClip (Abbott, Abbott Park, IL, USA) to achieve optimal outcome has become a challenge. With the opening of the Endovascular Valve Edge-to-Edge Repair Study criteria, the implant experience was extended towards functional mitral regurgitation and anatomically more complex mitral pathologies in many centers worldwide. We provide a review of the current literature to identify an appropriate patient selection process for MitraClip therapy and suggest a simple two-dimensional decision-making algorithm.

Entities:  

Keywords:  Anatomical predictors; Clinical predictors; MitraClip; Patient selection criteria; Transcatheter mitral repair

Mesh：

Year:  2016        PMID： 27796866     DOI： 10.1007/s11886-016-0809-7

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN： 1523-3782            Impact factor:   2.931


  40 in total

1.  The CARILLON Mitral Contour transcatheter indirect mitral valve annuloplasty system.

Authors:  Steven L Goldberg; Janusz Lipiecki; Horst Sievert
Journal:  EuroIntervention       Date:  2015-09       Impact factor: 6.534

2.  Recurrence of mitral regurgitation parallels the absence of left ventricular reverse remodeling after mitral repair in advanced dilated cardiomyopathy.

Authors:  Michele De Bonis; Elisabetta Lapenna; Alessandro Verzini; Giovanni La Canna; Antonio Grimaldi; Lucia Torracca; Francesco Maisano; Ottavio Alfieri
Journal:  Ann Thorac Surg       Date:  2008-03       Impact factor: 4.330

3.  One- and twelve-month safety and efficacy outcomes of patients undergoing edge-to-edge percutaneous mitral valve repair (from the GRASP Registry).

Authors:  Carmelo Grasso; Davide Capodanno; Salvatore Scandura; Stefano Cannata; Sebastiano Immè; Sarah Mangiafico; Anna Pistritto; Margherita Ministeri; Marco Barbanti; Anna Caggegi; Marta Chiarandà; Fabio Dipasqua; Sandra Giaquinta; Michele Occhipinti; Gianpaolo Ussia; Corrado Tamburino
Journal:  Am J Cardiol       Date:  2013-02-20       Impact factor: 2.778

4.  MitraClip therapy in surgical high-risk patients: identification of echocardiographic variables affecting acute procedural outcome.

Authors:  Edith Lubos; Michael Schlüter; Eik Vettorazzi; Britta Goldmann; Daniel Lubs; Johannes Schirmer; Hendrik Treede; Hermann Reichenspurner; Stefan Blankenberg; Stephan Baldus; Volker Rudolph
Journal:  JACC Cardiovasc Interv       Date:  2014-03-14       Impact factor: 11.195

5.  Early and mid-term outcomes of percutaneous mitral valve repair with the MitraClip®: comparative analysis of different EuroSCORE strata.

Authors:  Liliya Paranskaya; Giuseppe D'Ancona; Ilkay Bozdag-Turan; Ibrahim Akin; Stephan Kische; Gökmen R Turan; Dimitar Divchev; Tim C Rehders; Henrik Schneider; Jasmin Ortak; Christoph A Nienaber; Hüseyin Ince
Journal:  EuroIntervention       Date:  2012-09       Impact factor: 6.534

6.  Residual mitral valve regurgitation after percutaneous mitral valve repair with the MitraClip® system is a risk factor for adverse one-year outcome.

Authors:  Liliya Paranskaya; Giuseppe D'Ancona; Ilkay Bozdag-Turan; Ibrahim Akin; Stephan Kische; Gökmen R Turan; Tim Rehders; Jasmin Ortak; Christoph A Nienaber; Hüseyin Ince
Journal:  Catheter Cardiovasc Interv       Date:  2013-02-12       Impact factor: 2.692

7.  Guidelines on the management of valvular heart disease (version 2012): the Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS).

Authors:  Alec Vahanian; Ottavio Alfieri; Felicita Andreotti; Manuel J Antunes; Gonzalo Barón-Esquivias; Helmut Baumgartner; Michael Andrew Borger; Thierry P Carrel; Michele De Bonis; Arturo Evangelista; Volkmar Falk; Bernard Lung; Patrizio Lancellotti; Luc Pierard; Susanna Price; Hans-Joachim Schäfers; Gerhard Schuler; Janina Stepinska; Karl Swedberg; Johanna Takkenberg; Ulrich Otto Von Oppell; Stephan Windecker; Jose Luis Zamorano; Marian Zembala
Journal:  Eur J Cardiothorac Surg       Date:  2012-08-25       Impact factor: 4.191

Review 8.  Mitral valve repair versus replacement: is it a different story for percutaneous compared to surgical valve therapy?

Authors:  Devdas T Inderbitzin; Maurizio Taramasso; Fabian Nietlispach; Francesco Maisano
Journal:  J Cardiovasc Surg (Torino)       Date:  2016-04-01       Impact factor: 1.888

9.  Long-term survival and preprocedural predictors of mortality in high surgical risk patients undergoing percutaneous mitral valve repair.

Authors:  Andreas S Triantafyllis; Friso Kortlandt; Annelies L M Bakker; Martin J Swaans; Frank D Eefting; Jan A S van der Heyden; Martijn C Post; Benno W J M Rensing
Journal:  Catheter Cardiovasc Interv       Date:  2015-08-13       Impact factor: 2.692

10.  Failure of acute procedural success predicts adverse outcome after percutaneous edge-to-edge mitral valve repair with MitraClip.

Authors:  Miriam Puls; Tobias Tichelbäcker; Annalen Bleckmann; Mark Hünlich; Katrin von der Ehe; Bo Eric Beuthner; Karin Rüter; Tim Beißbarth; Ralf Seipelt; Friedrich Schöndube; Gerd Hasenfuß; Wolfgang Schillinger
Journal:  EuroIntervention       Date:  2014       Impact factor: 6.534
View more
  1 in total

1.  Atrial Fibrillation Predicts Long-Term Outcome after Transcatheter Edge-to-Edge Mitral Valve Repair by MitraClip Implantation.

Authors:  Mirjam Keßler; Alexander Pott; Elnura Mammadova; Julia Seeger; Jochen Wöhrle; Wolfgang Rottbauer; Sinisa Markovic
Journal:  Biomolecules       Date:  2018-11-19
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.